BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10901830)

  • 1. [Psychotropic drug use and associated factors in a professional environment].
    Picot MC; Abbar M; Chevalier A; Chastang JF; Luce D; Bonenfant S
    Encephale; 1996; 22(6):403-8. PubMed ID: 10901830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cross-sectional study of the prevalence of adjustment disorder with anxiety in general practice].
    Semaan W; Hergueta T; Bloch J; Charpak Y; Duburcq A; Le Guern ME; Alquier C; Rouillon F
    Encephale; 2001; 27(3):238-44. PubMed ID: 11488254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey].
    Grolleau A; Cougnard A; Bégaud B; Verdoux H
    Encephale; 2008 Sep; 34(4):352-9. PubMed ID: 18922237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
    Mathet F; Martin-Guehl C; Maurice-Tison S; Bouvard MP
    Encephale; 2003; 29(5):391-400. PubMed ID: 14615688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD).
    Demyttenaere K; Bonnewyn A; Bruffaerts R; De Girolamo G; Gasquet I; Kovess V; Haro JM; Alonso J
    J Affect Disord; 2008 Sep; 110(1-2):84-93. PubMed ID: 18329721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study)].
    Pélissolo A; André C; Chignon JM; Dutoit D; Martin P; Richard-Berthe C; Tignol J
    Encephale; 2002; 28(6 Pt 1):510-9. PubMed ID: 12506263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of trauma-related disorders in the French WHO study: Santé mentale en population générale (SMPG)].
    Vaiva G; Jehel L; Cottencin O; Ducrocq F; Duchet C; Omnes C; Genest P; Rouillon F; Roelandt JL
    Encephale; 2008 Dec; 34(6):577-83. PubMed ID: 19081454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition.
    Mergl R; Seidscheck I; Allgaier AK; Möller HJ; Hegerl U; Henkel V
    Depress Anxiety; 2007; 24(3):185-95. PubMed ID: 16900465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbid substance and mental disorders among rural Americans: results from the National Comorbidity Survey.
    Simmons LA; Havens JR
    J Affect Disord; 2007 Apr; 99(1-3):265-71. PubMed ID: 16978706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congruence between diagnosis of recurrent major depressive disorder and psychotropic treatment in the general population.
    Grolleau A; Cougnard A; Bégaud B; Verdoux H
    Acta Psychiatr Scand; 2008 Jan; 117(1):20-7. PubMed ID: 17970841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Personality disorders in a nonclinical sample of adolescents].
    Chabrol H; Chouicha K; Montovany A; Callahan S; Duconge E; Sztulman H
    Encephale; 2002; 28(6 Pt 1):520-4. PubMed ID: 12506264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A connection between insomnia and psychiatric disorders in the French general population].
    Ohayon MM; Lemoine P
    Encephale; 2002; 28(5 Pt 1):420-8. PubMed ID: 12386543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methodology of a study on insomnia in the general population].
    Ohayon MM
    Encephale; 2002; 28(3 Pt 1):217-26. PubMed ID: 12091782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety and psychoactive substance use disorder comorbidity in anorexia nervosa or depression.
    Jordan J; Joyce PR; Carter FA; Horn J; McIntosh VV; Luty SE; McKenzie JM; Mulder RT; Bulik CM
    Int J Eat Disord; 2003 Sep; 34(2):211-9. PubMed ID: 12898557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of bulimia among secondary school students in Casablanca].
    Ghazal N; Agoub M; Moussaoui D; Battas O
    Encephale; 2001; 27(4):338-42. PubMed ID: 11686055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of social support at work and in private life with mental health and antidepressant use: the Health 2000 Study.
    Sinokki M; Hinkka K; Ahola K; Koskinen S; Kivimäki M; Honkonen T; Puukka P; Klaukka T; Lönnqvist J; Virtanen M
    J Affect Disord; 2009 May; 115(1-2):36-45. PubMed ID: 18722019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of mental and physical health disorders among older methadone patients.
    Rosen D; Smith ML; Reynolds CF
    Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of health services for major depressive and anxiety disorders in Finland.
    Hämäläinen J; Isometsä E; Sihvo S; Pirkola S; Kiviruusu O
    Depress Anxiety; 2008; 25(1):27-37. PubMed ID: 17238158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.